1. Home
  2. NVNO vs BHM Comparison

NVNO vs BHM Comparison

Compare NVNO & BHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVNO
  • BHM
  • Stock Information
  • Founded
  • NVNO 1987
  • BHM 2022
  • Country
  • NVNO United States
  • BHM United States
  • Employees
  • NVNO N/A
  • BHM N/A
  • Industry
  • NVNO Medical/Dental Instruments
  • BHM Real Estate Investment Trusts
  • Sector
  • NVNO Health Care
  • BHM Real Estate
  • Exchange
  • NVNO Nasdaq
  • BHM Nasdaq
  • Market Cap
  • NVNO 41.0M
  • BHM 38.3M
  • IPO Year
  • NVNO N/A
  • BHM N/A
  • Fundamental
  • Price
  • NVNO $3.65
  • BHM $10.20
  • Analyst Decision
  • NVNO
  • BHM
  • Analyst Count
  • NVNO 0
  • BHM 0
  • Target Price
  • NVNO N/A
  • BHM N/A
  • AVG Volume (30 Days)
  • NVNO 76.7K
  • BHM 4.4K
  • Earning Date
  • NVNO 05-01-2025
  • BHM 01-01-0001
  • Dividend Yield
  • NVNO N/A
  • BHM 4.84%
  • EPS Growth
  • NVNO N/A
  • BHM N/A
  • EPS
  • NVNO N/A
  • BHM N/A
  • Revenue
  • NVNO N/A
  • BHM $62,151,000.00
  • Revenue This Year
  • NVNO N/A
  • BHM N/A
  • Revenue Next Year
  • NVNO $409.09
  • BHM N/A
  • P/E Ratio
  • NVNO N/A
  • BHM N/A
  • Revenue Growth
  • NVNO N/A
  • BHM 17.88
  • 52 Week Low
  • NVNO $2.03
  • BHM $9.30
  • 52 Week High
  • NVNO $6.48
  • BHM $19.01
  • Technical
  • Relative Strength Index (RSI)
  • NVNO 71.64
  • BHM 40.11
  • Support Level
  • NVNO $2.61
  • BHM $10.18
  • Resistance Level
  • NVNO $3.97
  • BHM $10.34
  • Average True Range (ATR)
  • NVNO 0.22
  • BHM 0.13
  • MACD
  • NVNO 0.11
  • BHM 0.08
  • Stochastic Oscillator
  • NVNO 80.00
  • BHM 69.23

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

About BHM Bluerock Homes Trust Inc.

Bluerock Homes Trust Inc owns and operates single-family properties that generate rental and other property-related income through the leasing of units to a diverse base of tenants. The properties are located in Sunbelt and the Western United States. The company's principal business objective is to generate attractive risk-adjusted investment returns by assembling a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities, located across a diverse group of growth markets. The company has two reportable segments scattered single-family homes and residential communities. The company generates the majority of its revenue from the Scattered single-family homes segment.

Share on Social Networks: